Ortho Clinical Diagnostics

Christopher Slachta Joins Cytovale as Chief Operating Officer

Retrieved on: 
Monday, March 4, 2024

SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced the appointment of Christopher Slachta, Ph.D., MBA, as the company's chief operating officer (COO). With more than 20 years of experience in the medical device and diagnostic industry, Slachta will lead operations as Cytovale ramps up production of its FDA-cleared rapid sepsis diagnosis test — IntelliSep®.

Key Points: 
  • SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Cytovale ® , a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced the appointment of Christopher Slachta, Ph.D., MBA, as the company's chief operating officer (COO).
  • With more than 20 years of experience in the medical device and diagnostic industry, Slachta will lead operations as Cytovale ramps up production of its FDA-cleared rapid sepsis diagnosis test — IntelliSep ® .
  • Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.
  • Ajay and his team have developed a proven solution with the potential to make a huge clinical impact on patient care," said Slachta.

Service Insight Unveils Revolutionary AIoT Solution for Biotech, Pharma, and Clinical Diagnostic Laboratories

Retrieved on: 
Wednesday, November 29, 2023

Service Insight Unveils Revolutionary AIoT Solution for Biotech, Pharma, and Clinical Diagnostic Laboratories

Key Points: 
  • Service Insight Unveils Revolutionary AIoT Solution for Biotech, Pharma, and Clinical Diagnostic Laboratories
    In a data-centric era, laboratories in biotech, pharmaceuticals, and diagnostics are increasingly adopting AI to gain a competitive edge and make data-driven decisions.
  • To bridge this gap, Service Insight introduces the Smart Lab solution, a pivotal capability designed to capture essential missing data for driving AI models that address scientific reproducibility.
  • Anthony Uzzo, CEO of Service Insight, shares his vision: "At Service Insight, our mission is to be a catalyst for digital transformation in how businesses manage their operations.
  • Elevating Clinical Diagnostics & Hospital Labs:
    Service Insight introduces AIoT solutions to enhance efficiency and traceability in Clinical Diagnostic and Hospital Labs.

Labroots Announces Agenda for its 14th Annual Clinical Diagnostics & Research Online Event - held on November 8th, 2023

Retrieved on: 
Monday, November 6, 2023

YORBA LINDA, Calif., Nov. 6, 2023 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 14th annual event in the Clinical Diagnostics & Research Virtual Event Series scheduled on November 8, 2023. This event will continue its long-standing commitment to advance clinical diagnostics, novel research and medicine, and to align research scholars, clinicians, top scientists, healthcare professionals and experts from leading academia and industry institutions under a virtual roof on a global basis.

Key Points: 
  • YORBA LINDA, Calif., Nov. 6, 2023 /PRNewswire-PRWeb/ -- Labroots , the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 14th annual event in the Clinical Diagnostics & Research Virtual Event Series scheduled on November 8, 2023.
  • Attendees will also see multiple panels and presentations from key industry sponsors including, Sartorius, Thermo Fisher Scientific, and Roche Diagnostics.
  • Use the hashtag #LRclinical to follow the conversation and connect with other members of the global Clinical & Molecular Dx Community!
  • Join our Clinical & Molecular Dx Interest Group on LinkedIn to connect with us, and the wider professional community!

Syncell Appoints Life Science Industry Leaders Dr. Martin Madaus and Dr. Don Kania as Business Strategic Advisors

Retrieved on: 
Thursday, October 19, 2023

Syncell, a life science technology company developing tools for next-generation proteome research, proudly announces the appointment of Dr. Martin Madaus and Dr. Don Kania as the new Business Strategic Advisors of the company.

Key Points: 
  • Syncell, a life science technology company developing tools for next-generation proteome research, proudly announces the appointment of Dr. Martin Madaus and Dr. Don Kania as the new Business Strategic Advisors of the company.
  • With their extensive backgrounds in the life science industry, both Dr. Madaus and Dr. Kania will guide Syncell's growth and innovation, helping the company become a major player in the spatial proteomics industry.
  • Dr. Madaus shared enthusiasm about his new role: “Syncell is pushing the boundaries of spatial proteomics with its innovative Microscoop technology.
  • As strategic business advisors, Dr. Madaus and Dr. Kania will provide guidance and collaborate with Syncell on various aspects of its operations, including business strategy, commercialization planning, product development, and fundraising efforts.

Invitae Appoints Dr. David Sholehvar as Chief Operating Officer

Retrieved on: 
Thursday, October 19, 2023

SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.

Key Points: 
  • SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.
  • "I'm excited to welcome Dr. Sholehvar to the Invitae leadership team.
  • His extensive general management experience in both large and small healthcare companies, as well as global functional leadership in sales, marketing, strategy and innovation will be an enormous benefit to Invitae as we continue our focus on operational excellence and innovation," said Ken Knight, president and chief executive officer of Invitae.
  • From 2017 to 2020, Dr. Sholehvar served as chief executive officer for Dynex Technologies, Inc., a manufacturer of laboratory instruments and associated consumables and accessories, where his focus was transforming Dynex's business model.

Native Des Moines resident opens Top Rail Fence in Iowa

Retrieved on: 
Wednesday, October 11, 2023

DES MOINES, Iowa, Oct. 11, 2023 /PRNewswire/ -- Top Rail Fence, the on-time professionals in fence design, quality, installation and service, today announced the grand opening of its first location in Iowa, serving the greater Des Moines area. The location is owned by Bret and Jill Staples.

Key Points: 
  • DES MOINES, Iowa, Oct. 11, 2023 /PRNewswire/ -- Top Rail Fence , the on-time professionals in fence design, quality, installation and service, today announced the grand opening of its first location in Iowa, serving the greater Des Moines area.
  • The couple had previously introduced themselves and their new Top Rail Fence Des Moines location at the Iowa Association of Realtors Annual Convention at the Marriot Downtown on Sept. 26–28.
  • Top Rail Fence Des Moines will serve the residents of Altoona, Ames, Ankeny, Booneville, Clive, Des Moines, Grimes, Indianola, Johnston, Lovington, Marquisville, Saylorville, Spring Hill, Summerset, Swanwood, Urbandale, Waukee and West Des Moines, Iowa.
  • To learn more about Top Rail Fence Des Moines, please visit https://toprailfence.com/locations/des-moines/ .

Laboratory Proficiency Testing Market worth $1.6 billion | MarketsandMarkets

Retrieved on: 
Wednesday, October 4, 2023

In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.

Key Points: 
  • In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.
  • In 2022, the cell culture segment held the largest market share in the Laboratory Proficiency Testing market.
  • The APAC Laboratory Proficiency Testing market is projected to grow at the highest rate during the forecast period.
  • The laboratory proficiency testing market is segmented into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Laboratory Proficiency Testing Market worth $1.6 billion | MarketsandMarkets

Retrieved on: 
Wednesday, October 4, 2023

In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.

Key Points: 
  • In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.
  • In 2022, the cell culture segment held the largest market share in the Laboratory Proficiency Testing market.
  • The APAC Laboratory Proficiency Testing market is projected to grow at the highest rate during the forecast period.
  • The laboratory proficiency testing market is segmented into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The TJX Companies, Inc. Elects Charles F. Wagner, Jr. to Board of Directors

Retrieved on: 
Friday, September 22, 2023

The TJX Companies, Inc. (NYSE: TJX), the leading off-price apparel and home fashions retailer in the U.S. and worldwide, announced today that on September 20, 2023, its Board of Directors elected Charles (Charlie) F. Wagner, Jr. to the Board, effective immediately.

Key Points: 
  • The TJX Companies, Inc. (NYSE: TJX), the leading off-price apparel and home fashions retailer in the U.S. and worldwide, announced today that on September 20, 2023, its Board of Directors elected Charles (Charlie) F. Wagner, Jr. to the Board, effective immediately.
  • Mr. Wagner is Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, Inc., a role he has served in since 2019.
  • In this role, he oversees a range of functions for Vertex including accounting, finance, internal audit, investor relations, business development, and global security and facilities functions.
  • Carol Meyrowitz, Executive Chairman of the Board of The TJX Companies, Inc., stated, “We are delighted to have Charlie join TJX as the newest member of our Board of Directors.

Trinity Life Sciences Appoints Advisory Board

Retrieved on: 
Wednesday, September 20, 2023

Trinity Life Sciences , a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission .

Key Points: 
  • Trinity Life Sciences , a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission .
  • Trinity is the fourth company Mr. Corcoran has founded or co-founded, after successful endeavors in social media, medical devices, and pharma- and biotech-focused software development.
  • “My team and I are thrilled to be working with the foremost innovative thinkers in our industry,” said Leslie Orne , President & CEO of Trinity Life Sciences.
  • “Their combined expertise is second to none and will serve as guiding voices as Trinity continues to transform the way life sciences companies think about and execute on their goals.”